Medtronic announces FDA approval of minimally invasive device to treat hypertension

The Symplicityâ„¢ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology DUBLIN, Nov. 17, 2023 /PRNewswire/ — Medtronic plc (NYSE:…